The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

Abstract Introduction Resistance to immune checkpoint inhibitors (ICI) is a significant issue in metastatic renal cell carcinoma (mRCC), as it is in the majority of cancer types. An important deficiency in immunooncology today is the lack of a predictive factor to identify this patient group. Myeloi...

Full description

Bibliographic Details
Main Authors: Volkan Aslan, Atiye Cenay Karabörk Kılıç, Ahmet Özet, Aytuğ Üner, Nazan Günel, Ozan Yazıcı, Gözde Savaş, Ahmet Bayrak, Emrah Eraslan, Berna Öksüzoğlu, Hüseyin Koray Kılıç, Nuriye Özdemir
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Cancer
Subjects:
Immune checkpoint inhibitor
Splenic volume
mRCC
Systemic inflammation
Online Access:https://doi.org/10.1186/s12885-023-11558-y

Internet

https://doi.org/10.1186/s12885-023-11558-y

Similar Items